Week in Review: January 6

By Samantha Rossi • January 6, 2023

Share this:

The Week in Review provides an overview of the past week’s top health care content, including industry news and trends, Mayo Clinic and Mayo Clinic Laboratories news, and upcoming events.

Industry News

Public health agencies try to restore trust as they fight misinformation

Across the country, health officials have been trying to combat misinformation and restore trust within their communities these past few years, a period when many people haven’t put full faith in their state and local health departments. Source: Kaiser Health News

Read article.

Telehealth brings expert sexual assault exams to rural patients

TeleSANE services are expanding across the country in rural, sparsely populated areas. Research shows SANE programs encourage psychological healing, provide comprehensive health care, allow for professional evidence collection, and improve the chance of a successful prosecution. Source: Kaiser Health News

Read article.

FDA decision on experimental Alzheimer’s drug expected this week

The US Food and Drug Administration could decide this week whether to grant accelerated approval to the experimental dementia drug lecanemab, according to Eisai and Biogen, the companies that make the drug. Source: CNN

Read article.

Samantha Rossi

Samantha Rossi is a Digital Marketing Manager at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Samantha has worked at Mayo Clinic since 2019.